Group One Trading
CLRB icon

Group One Trading’s Cellectar Biosciences CLRB Stock Holding History

Group One Trading’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23
Closed -$129 – 8234
2025
Q3 		$129 Sell
23
-33
-59% -$163 ﹤0.01% 8235
2025
Q2 		$398 Buy
56
+9
+19% +$79 ﹤0.01% 7688
2025
Q1 		$441 Hold
47
– – ﹤0.01% 7294
2024
Q4 		$418 Hold
47
– – ﹤0.01% 7021
2024
Q3 		$2.99K Sell
47
-118
-72% -$7.78K ﹤0.01% 6045
2024
Q2 		$12.4K Sell
165
-102
-38% -$9.79K ﹤0.01% 5522
2024
Q1 		$31.8K Buy
+267
New +$28.9K ﹤0.01% 5071

Other funds holding CLRB

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading's CLRB Position: Q4 2025 in Review

Group One Trading sold out of Cellectar Biosciences (CLRB) in Q4 2025, closing a stake of 23 shares — an estimated $129 sold.

Group One Trading first reported a position in CLRB in Q1 2024 and held it in 7 quarters. The position peaked at $31.8K in Q1 2024. 20 funds tracked by Wall St. Rank hold CLRB as of Q4 2025.

  • Group One Trading reported no remaining Cellectar Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 23 Cellectar Biosciences shares in Q4 2025, an estimated $129.
  • Group One Trading first reported a position in Cellectar Biosciences in Q1 2024 and held it in 7 quarters.
  • Group One Trading's Cellectar Biosciences position peaked at $31.8K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.